{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:15:00Z","timestamp":1769354100794,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470748"],"award-info":[{"award-number":["82470748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070752"],"award-info":[{"award-number":["82070752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170737"],"award-info":[{"award-number":["82170737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370707"],"award-info":[{"award-number":["82370707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102970"],"award-info":[{"award-number":["82102970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705103"],"award-info":[{"award-number":["2022YFC2705103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705100"],"award-info":[{"award-number":["2022YFC2705100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705104"],"award-info":[{"award-number":["2022YFC2705104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"publisher","award":["2022B1515020106"],"award-info":[{"award-number":["2022B1515020106"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"publisher","award":["2023A1515012477"],"award-info":[{"award-number":["2023A1515012477"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory of National Health Commission","award":["2002B60118"],"award-info":[{"award-number":["2002B60118"]}]},{"name":"Key Laboratory of Nephrology, Guangdong Province, Guangzhou, China","award":["2020B1212060028"],"award-info":[{"award-number":["2020B1212060028"]}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["202201020273"],"award-info":[{"award-number":["202201020273"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Municipal Programme of Science and Technology","award":["2024B03J1337"],"award-info":[{"award-number":["2024B03J1337"]}]},{"name":"Guangzhou Municipal Programme of Science and Technology","award":["202201010166"],"award-info":[{"award-number":["202201010166"]}]},{"name":"Science and Technology Projects in Guangzhou, China","award":["2023A04J0613"],"award-info":[{"award-number":["2023A04J0613"]}]},{"name":"Science and Technology Projects in Guangzhou, China","award":["2024A04J4000"],"award-info":[{"award-number":["2024A04J4000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Thrombotic microangiopathy (TMA) is a major complication of malignant hypertension (mHTN). Abnormal complement activation has been recognized as a key determinant of TMA, but less is known about the prognostic significance of complement abnormality in patients with mHTN-associated TMA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort study was performed in patients with mHTN. All participants had concomitant TMA proven by kidney biopsy after admission between 2008 and 2023, and were divided into normal and abnormal complement groups based on serum C3 and C4 levels. Cox regression models were used to identify risk factors for renal prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 189 mHTN patients with TMA were enrolled in the current study, including 161 (85.2%) patients with normal complement levels and 28 (14.8%) patients with abnormal complement levels. Compared to the normal complement group, patients in the abnormal complement group had lower levels of BMI, hemoglobin, and platelet counts, and more intravascular erythrocyte fragments (21.4% vs 7.5%, P\u00a0=\u00a0.02). Notably, a substantial glomerular deposition of C3c and C5b-9 was observed in the abnormal complement group, indicating complement activation in vivo. Importantly, abnormal complement levels were independently associated with worse renal function recovery [hazard ratio (HR), 0.368; 95% CI, 0.140\u20130.970; P\u00a0=\u00a0.043]. In addition, the glomerular sclerosis ratio (HR, 0.971; 95% CI, 0.953\u20130.989; P\u00a0=\u00a0.002) remained an independent predictor of poor renal outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with abnormal complement levels have worse renal prognosis, suggesting that complement abnormality predisposes to the progression of mHTN-associated TMA disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf235","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:43:44Z","timestamp":1753357424000},"source":"Crossref","is-referenced-by-count":1,"title":["Complement abnormality predisposes to the development of malignant hypertension-associated thrombotic microangiopathy disease"],"prefix":"10.1093","volume":"18","author":[{"given":"Rong","family":"Lian","sequence":"first","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Nephrology, , Guangzhou ,","place":["China"]},{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Clinical Medical Research, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchuan","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejiao","family":"Li","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Nephrology, , Guangzhou ,","place":["China"]},{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Clinical Medical Research, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinji","family":"Lian","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Geriatrics, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengyou","family":"Yu","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Clinical Medical Research, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxin","family":"Shi","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Sun Yat-sen University, NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-8040","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Sun Yat-sen University, NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Sun Yat-sen University, NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"He","sequence":"additional","affiliation":[{"name":"Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology Department of Nephrology, , Guangzhou ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"2025082305315911700_bib1","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/ndt\/gfac324","article-title":"Nephrosclerosis in young patients with malignant hypertension","volume":"38","author":"Bureau","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025082305315911700_bib2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/bmj.1.5134.1361","article-title":"Hypertension: Treated and untreated; a study of 400 cases","volume":"1","author":"Leishman","year":"1959","journal-title":"Br Med J"},{"key":"2025082305315911700_bib3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1681\/ASN.V91133","article-title":"Malignant hypertension and hypertensive emergencies","volume":"9","author":"Kitiyakara","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2025082305315911700_bib4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero","year":"2019","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/ndt\/gfac248","article-title":"Thrombotic microangiopathy in patients with malignant hypertension","volume":"38","author":"Cavero","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025082305315911700_bib6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/HJH.0000000000001913","article-title":"Malignant hypertension: Diagnosis, treatment and prognosis with experience from the Bordeaux cohort","volume":"37","author":"Rubin","year":"2019","journal-title":"J Hypertens"},{"key":"2025082305315911700_bib7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"van den Born","year":"2005","journal-title":"Hypertension"},{"key":"2025082305315911700_bib8","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Long-term renal survival in malignant hypertension","volume":"25","author":"Gonzalez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2025082305315911700_bib9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.42681","article-title":"Clinical evaluation and management of thrombotic microangiopathy","volume":"76","author":"Leisring","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2025082305315911700_bib10","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"van den Born","year":"2006","journal-title":"J Hypertens"},{"key":"2025082305315911700_bib11","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans","year":"2017","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ckj\/sfx081","article-title":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: Accumulating evidence, but not a panacea","volume":"10","author":"Brocklebank","year":"2017","journal-title":"Clin Kidney J"},{"key":"2025082305315911700_bib13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40620-016-0357-7","article-title":"Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: Case reports and a review of the evidence for treatment with eculizumab","volume":"30","author":"Asif","year":"2017","journal-title":"J Nephrol"},{"issue":"6","key":"2025082305315911700_bib14","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2025082305315911700_bib15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","article-title":"Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension","volume":"51","author":"van den Born","year":"2008","journal-title":"Hypertension"},{"key":"2025082305315911700_bib16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: A review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2025082305315911700_bib17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1523-1755.2004.00835.x","article-title":"Signs and symptoms of thin basement membrane nephropathy: A prospective regional study on primary glomerular disease\u2014The Limburg Renal Registry","volume":"66","author":"Van Paassen","year":"2004","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025082305315911700_bib19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.kint.2017.02.025","article-title":"Severe hypertension with renal thrombotic microangiopathy: What happened to the usual suspect?","volume":"91","author":"Van Laecke","year":"2017","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1291\/hypres.31.479","article-title":"Renal thrombotic microangiopathies induced by severe hypertension","volume":"31","author":"ZHANG","year":"2008","journal-title":"Hypertens Res"},{"key":"2025082305315911700_bib21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/2040620715571076","article-title":"Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura","volume":"6","author":"Khanal","year":"2015","journal-title":"Ther Adv Hematol"},{"key":"2025082305315911700_bib22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): Can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"key":"2025082305315911700_bib23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"key":"2025082305315911700_bib24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.14336\/AD.2019.0119","article-title":"Significance of complement system in ischemic stroke: A comprehensive review","volume":"10","author":"Ma","year":"2019","journal-title":"Aging Dis"},{"key":"2025082305315911700_bib25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: From rare diseases to pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol Rev"},{"key":"2025082305315911700_bib26","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1111\/bph.16097","article-title":"Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease","volume":"180","author":"Bode","year":"2023","journal-title":"Br J Pharmacol"},{"key":"2025082305315911700_bib27","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 Formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2025082305315911700_bib28","article-title":"Association between thrombotic microangiopathy and activated alternative complement pathway in malignant nephrosclerosis","author":"Zhang","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2025082305315911700_bib29","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/ajh.26854","article-title":"Complement-driven hemolytic uremic syndrome","volume":"98","author":"Leon","year":"2023","journal-title":"Am J Hematol"},{"key":"2025082305315911700_bib30","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1111\/bph.15171","article-title":"The role of complement in arterial hypertension and hypertensive end organ damage","volume":"178","author":"Wenzel","year":"2021","journal-title":"Br J Pharmacol"},{"key":"2025082305315911700_bib31","doi-asserted-by":"publisher","DOI":"10.1177\/1355819612473592","article-title":"Not enough doctors or not enough needs? Refocusing health workforce planning from providers and services to populations and needs","volume":"18","author":"Birch","year":"2013","journal-title":"J Health Serv Res Policy"},{"key":"2025082305315911700_bib32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.kint.2020.09.033","article-title":"Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis","volume":"99","author":"Boudhabhay","year":"2021","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jash.2015.12.007","article-title":"The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy","volume":"10","author":"Mathew","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"2025082305315911700_bib34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1172\/JCI116237","article-title":"Requirements for leukocyte adhesion molecules in nephrotoxic nephritis","volume":"91","author":"Mulligan","year":"1993","journal-title":"J Clin Invest"},{"key":"2025082305315911700_bib35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1172\/JCI117326","article-title":"Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat","volume":"94","author":"Wu","year":"1994","journal-title":"J Clin Invest"},{"key":"2025082305315911700_bib36","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2215\/CJN.0000000000000295","article-title":"Characteristics of complement protein deposition in proliferative glomerulonephritis with monoclonal immunoglobulin deposition","volume":"18","author":"Liu","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025082305315911700_bib37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.kint.2017.03.049","article-title":"The perfect storm","volume":"92","author":"Ruderman","year":"2017","journal-title":"Kidney Int"},{"key":"2025082305315911700_bib38","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf235\/63841113\/sfaf235.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf235\/63841113\/sfaf235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf235\/63841113\/sfaf235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T09:32:02Z","timestamp":1755941522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf235\/8211806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf235","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,24]]},"article-number":"sfaf235"}}